Angiopoietin-like 3 inhibition and the liver: less is more?
Journal Information
Full Title: Curr Opin Lipidol
Abbreviation: Curr Opin Lipidol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflicts of interest There are no conflicts of interest. There are no conflicts of interest."
Funding Disclosure
Evidence found in paper:
"Financial support and sponsorship E.S.G.S. was supported by the Netherlands Heart Foundation CVON 2017-20: generating the best evidence-based pharmaceutical targets for atherosclerosis [GENIUS II]. G.K.H. is employed part-time by Novo Nordisk and owns shares. R.F.O. has no disclosures."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025